Don’t miss the opportunity to apply for this great program through @ACCinTouch, the Clinical Trials Research program!
The faculty are excellent and you learn so much from your cohort! @MinnowWalsh@TYWangMD@pamelasdouglas@MelvinEchols9
https://t.co/fLSUNz4ZFR
How can clinical trials include a more representative patient population? @TYWangMD argues that a large-scale paradigm shift is required, with patients engaged at every stage from research design to conduct.
Read the whole article here ⬇️
🔗 https://t.co/74O1gB8YT1
Trying to solve clinical and social determinant dilemmas in #QCOR! “Let’s not miss the elephant in the room!” From @DrLaPrincess science and implementation need to be informed by community perspectives and partnerships
“We are tied together in our mission to improve heart health for all. We have a common sense of purpose.” - @TYWangMD
ACC's Clinical Trials Research course Day 1️⃣ kicks off with a welcome and reminder on the importance of increasing diversity in clinical trials by supporting individuals from traditionally underrepresented communities in cardiology. 🔎 https://t.co/3aLItM63hq #ACCDiversity
@PCORI Annual Meeting talking about #mental health prevention: research needs to involve all people: patients, clinicians, purchasers and policymakers. Mental health is a crisis that we can only solve together.
Among patients with suspected sepsis and no clear indication for antianaerobic coverage, administration of piperacillin-tazobactam was associated with higher mortality and increased duration of organ dysfunction compared with cefepime. https://t.co/8fjKf4ujal
🆕AHA statement on Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risk and Approach to Management.
This scientific statement presents an interdisciplinary approach for the assessment and management of CS in older adults.
✍🏼 @vbluml
🔗 https://t.co/I5RvDKHMz2